Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and l-dopa, in bilateral 6-OHDA-lesioned rat-Reference-Cited by-同舟云学术

Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and l-dopa, in bilateral 6-OHDA-lesioned rat

Published:2013-07 Issue: Volume:70 Page:74-82
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Zengin-Toktas Yildiz,Authier Nicolas,Denizot Hélène,Chassain Carine,Hafidi Aziz,Llorca Pierre M.,Durif Franck

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference68 articles.

1. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434;Abrahams;Eur. J. Pharmacol.,1998

2. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography;Brooks;Ann. Neurol.,1992

3. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa;Bordet;Proc. Natl. Acad. Sci. U. S. A.,1997

4. Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease;Corvol;J. Neurosci.,2004

5. Psychiatric and sexual disorders induced by apomorphine in Parkinson disease;Courty;Clin. Neuropharmacol.,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emission of 50-kHz ultrasonic vocalizations stimulated by antiparkinsonian dopaminomimetic drugs in hemiparkinsonian rats is associated with neuronal activation in subcortical regions that regulate the affective state;Experimental Neurology;2024-11

2. Rewarding properties of L-Dopa in experimental parkinsonism are mediated by sensitized dopamine D1 receptors in the dorsal striatum;Molecular Psychiatry;2024-09-03

3. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders;Neurobiology of Disease;2024-08

4. Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2024-04

5. Cortico-striatal gamma oscillations are modulated by dopamine D3 receptors in dyskinetic rats;Neural Regeneration Research;2024-03-01